EMMAC is committed to meet the growing demand for premium quality CBD and wellness products across Europe.

With the acquisition of Blossom, EMMAC has acquired a market leading Swiss wellness CBD Company. Founded in 2017, Blossom has quickly become a reference in the Swiss market and is ideally positioned to expand its activities into the Swiss medical cannabis market as well as building on the strength of the portfolio in other key European markets.

“We project the European CBD and wellness market to grow to between €2.8bn and €3.8bn by 2022.” – Cannacord Genuity.

Visit the Blossom Website